Table 4A. Multivariate analysis—age controlled injury effects on CFT/Raclopride binding.
| Variable |
Caudate—CFT: R2=0.494 |
Putamen—CFT: R2=0.668 |
Striatum—CFT: R2=0.225 |
|||
|---|---|---|---|---|---|---|
| Estimate | P-value | Estimate | P-value | Estimate | P-value | |
| Intercept | 5.463 | <0.001 | 4.024 | <0.001 | 3.563 | <0.001 |
| Age | −0.054 | 0.012 | −0.027 | 0.054 | −0.013 | 0.466 |
| Injury status | 1.300 | 0.002 | 1.482 | <0.001 | 0.773 | 0.029 |
|
Caudate—RAC: R2=0.172 |
Putamen—RAC: R2=0.255 |
Striatum—RAC: R2=0.209 |
||||
|---|---|---|---|---|---|---|
| Estimate | P-value | Estimate | P-value | Estimate | P-value | |
| Intercept | 3.193 | <0.001 | 3.280 | <0.001 | 3.102 | <0.001 |
| Age | −0.013 | 0.080 | −0.015 | 0.018 | −0.011 | 0.173 |
| Injury status | −0.155 | 0.245 | 0.092 | 0.393 | −0.276 | 0.055 |
DAT, dopamine transporter; DRD2, D2 receptor gene.
Bold entries are made for P-values representing comparisons that are statistically significant.